These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 14562104)

  • 1. RNA molecules stimulate prion protein conversion.
    Deleault NR; Lucassen RW; Supattapone S
    Nature; 2003 Oct; 425(6959):717-20. PubMed ID: 14562104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breakage of PrP aggregates is essential for efficient autocatalytic propagation of misfolded prion protein.
    Piening N; Weber P; Giese A; Kretzschmar H
    Biochem Biophys Res Commun; 2005 Jan; 326(2):339-43. PubMed ID: 15582583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient in vitro amplification of a mouse-adapted scrapie prion protein.
    Murayama Y; Yoshioka M; Yokoyama T; Iwamaru Y; Imamura M; Masujin K; Yoshiba S; Mohri S
    Neurosci Lett; 2007 Feb; 413(3):270-3. PubMed ID: 17174030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro amplification of protease-resistant prion protein requires free sulfhydryl groups.
    Lucassen R; Nishina K; Supattapone S
    Biochemistry; 2003 Apr; 42(14):4127-35. PubMed ID: 12680767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of transition metals (Mn, Cu, Fe) and deoxycholic acid (DA) on the conversion of PrPC to PrPres.
    Kim NH; Choi JK; Jeong BH; Kim JI; Kwon MS; Carp RI; Kim YS
    FASEB J; 2005 May; 19(7):783-5. PubMed ID: 15758042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sc237 hamster PrPSc and Sc237-derived mouse PrPSc generated by interspecies in vitro amplification exhibit distinct pathological and biochemical properties in tga20 transgenic mice.
    Yoshioka M; Imamura M; Okada H; Shimozaki N; Murayama Y; Yokoyama T; Mohri S
    Microbiol Immunol; 2011 May; 55(5):331-40. PubMed ID: 21362027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding.
    Saborio GP; Permanne B; Soto C
    Nature; 2001 Jun; 411(6839):810-3. PubMed ID: 11459061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro generation of infectious scrapie prions.
    Castilla J; Saá P; Hetz C; Soto C
    Cell; 2005 Apr; 121(2):195-206. PubMed ID: 15851027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prion protein conversion in vitro.
    Supattapone S
    J Mol Med (Berl); 2004 Jun; 82(6):348-56. PubMed ID: 15014886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro prion protein conversion in detergent-solubilized membranes.
    Nishina K; Deleault NR; Lucassen RW; Supattapone S
    Biochemistry; 2004 Mar; 43(9):2613-21. PubMed ID: 14992599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro amplification of scrapie and chronic wasting disease PrP(res) using baculovirus-expressed recombinant PrP as substrate.
    Faburay B; Tark D; Kanthasamy AG; Richt JA
    Prion; 2014; 8(6):393-403. PubMed ID: 25495764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prion diseases: a nucleic-acid accomplice?
    Caughey B; Kocisko DA
    Nature; 2003 Oct; 425(6959):673-4. PubMed ID: 14562085
    [No Abstract]   [Full Text] [Related]  

  • 14. Reduction of prion infectivity and levels of scrapie prion protein by lithium aluminum hydride: implications for RNA in prion diseases.
    Jeong BH; Kim NH; Jin JK; Choi JK; Lee YJ; Kim JI; Choi EK; Carp RI; Kim YS
    J Neuropathol Exp Neurol; 2009 Aug; 68(8):870-9. PubMed ID: 19606066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PrP(Sc) of scrapie 263K propagates efficiently in spleen and muscle tissues with protein misfolding cyclic amplification.
    Shi S; Dong CF; Wang GR; Wang X; An R; Chen JM; Shan B; Zhang BY; Xu K; Shi Q; Tian C; Gao C; Han J; Dong XP
    Virus Res; 2009 Apr; 141(1):26-33. PubMed ID: 19162101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice.
    Pfeifer A; Eigenbrod S; Al-Khadra S; Hofmann A; Mitteregger G; Moser M; Bertsch U; Kretzschmar H
    J Clin Invest; 2006 Dec; 116(12):3204-10. PubMed ID: 17143329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-free formation of misfolded prion protein with authentic prion infectivity.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Proc Natl Acad Sci U S A; 2006 Oct; 103(43):15818-23. PubMed ID: 17030802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences between the prion protein and its homolog Doppel: a partially structured state with implications for scrapie formation.
    Nicholson EM; Mo H; Prusiner SB; Cohen FE; Marqusee S
    J Mol Biol; 2002 Feb; 316(3):807-15. PubMed ID: 11866533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental approaches to the interaction of the prion protein with nucleic acids and glycosaminoglycans: Modulators of the pathogenic conversion.
    Silva JL; Vieira TC; Gomes MP; Rangel LP; Scapin SM; Cordeiro Y
    Methods; 2011 Mar; 53(3):306-17. PubMed ID: 21145399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anchorless prion protein results in infectious amyloid disease without clinical scrapie.
    Chesebro B; Trifilo M; Race R; Meade-White K; Teng C; LaCasse R; Raymond L; Favara C; Baron G; Priola S; Caughey B; Masliah E; Oldstone M
    Science; 2005 Jun; 308(5727):1435-9. PubMed ID: 15933194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.